Skip to main content
. 2022 Nov 30;20(4):725–736. doi: 10.9758/cpn.2022.20.4.725

Fig. 2.

Fig. 2

(A) Sociability, (B) sociability index, (C) social preference, and (D) social preference index on Three-Chamber Sociability and Social Novelty Test apparatus. (A) Stranger: aF1, 42 = 106.277; bF2, 42 = 31.543; Empty: aF1, 42 = 228.979; bF2, 42 = 68.632. (B) Sociability index: aF1, 42 = 502.727; bF2, 42 = 131.026. (C) Familiar: aF1, 42 = 502.086; bF2, 42 = 60.493; Novel: aF1, 42 = 1,477.037; bF2, 42 = 421.444. (D) Social preference index: aF1, 42 = 2,585.419; bF2, 42 = 444.524.

Pre-VPA, prenatal valproic acid; D1, dose 1; D2, dose 2; Nimo, nimodipine.

Results are mean ± standard deviation, two-way ANOVA followed by Bonferroni’s post-test. app < 0.05 vs. control rats, bpp < 0.05 vs. Pre-VPA treated rats.